You are here
Executive Director, Nevada Institute for Personalized Medicine
Professor of Life Sciences
Expertise: AIDS/HIV, Alzheimer's disease, Genetics, Bioinformatics
Martin Schiller's work is focused on short functional peptides, bioinformatics, and HIV. Schiller’s research has resulted in 60 publications supported mostly by 12 research grants from the National Institutes of Health.
He has received a number of awards, produced a suite of bioinformatics tools, and is involved in commercialization of some of his research projects. He is now the executive director of the Nevada Institute of Personalized Medicine.
Martin Schiller In The News
Martin Schiller’s research lab at UNLV is creating far more than just experiments. The research completed inside the Schiller Laboratory of Applied Bioinformatics has led to Schiller’s Heligenics, a startup that could help genetics testing companies shine a light on undiagnosed diseases.
With a new $11.4 million grant from the National Institutes of Health, UNLV wants to help the country move to a more data-driven approach to medicine.
On May 6, the “All of Us” study started enrolling participants. This national study will be one of the largest ever examining the connection between genetics, behavior and medical outcomes, with a goal of 1 million or more participants. Anyone over the age of 18 in the U.S. can join.
Tracing your family roots. It's research that can turn up all kinds of surprises, and maybe even links to famous ancestors.
Articles Featuring Martin Schiller
Funding from National Institutes of Health will support human genetics research, develop pipeline of scientists working to make Nevada a leader in personalized medicine.
UNLV faculty discoveries have commercial applications with value to the university, the private sector, and, ultimately, you. Learn about UNLV life sciences professor Martin Schiller, who is working to move his innovative thinking out of the laboratory and into the boardroom.